PT915087E - Compostos anelados de cinco aneis, susbtituidos por sulfonamida, sua utilizacao como medicamentos, bem como preparacoes farmaceuticas contendo os mesmos - Google Patents

Compostos anelados de cinco aneis, susbtituidos por sulfonamida, sua utilizacao como medicamentos, bem como preparacoes farmaceuticas contendo os mesmos

Info

Publication number
PT915087E
PT915087E PT98120913T PT98120913T PT915087E PT 915087 E PT915087 E PT 915087E PT 98120913 T PT98120913 T PT 98120913T PT 98120913 T PT98120913 T PT 98120913T PT 915087 E PT915087 E PT 915087E
Authority
PT
Portugal
Prior art keywords
medications
sulfonamide
preparations
same
products containing
Prior art date
Application number
PT98120913T
Other languages
English (en)
Inventor
Joachim Brendel
Jochen Lang Dr Hans
Gerlach Dr Uwe
Weidmann Dr Kalus
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT915087E publication Critical patent/PT915087E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT98120913T 1997-11-10 1998-11-04 Compostos anelados de cinco aneis, susbtituidos por sulfonamida, sua utilizacao como medicamentos, bem como preparacoes farmaceuticas contendo os mesmos PT915087E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19749453A DE19749453A1 (de) 1997-11-10 1997-11-10 Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
PT915087E true PT915087E (pt) 2003-08-29

Family

ID=7848065

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98120913T PT915087E (pt) 1997-11-10 1998-11-04 Compostos anelados de cinco aneis, susbtituidos por sulfonamida, sua utilizacao como medicamentos, bem como preparacoes farmaceuticas contendo os mesmos

Country Status (29)

Country Link
US (1) US6015822A (pt)
EP (1) EP0915087B1 (pt)
JP (1) JP4331809B2 (pt)
KR (1) KR19990045147A (pt)
CN (1) CN1219533A (pt)
AR (1) AR016006A1 (pt)
AT (1) ATE236120T1 (pt)
AU (1) AU742199B2 (pt)
BR (1) BR9804995A (pt)
CA (1) CA2253211C (pt)
CZ (1) CZ363798A3 (pt)
DE (2) DE19749453A1 (pt)
DK (1) DK0915087T3 (pt)
ES (1) ES2196456T3 (pt)
HR (1) HRP980585B1 (pt)
HU (1) HUP9802590A3 (pt)
ID (1) ID21282A (pt)
IL (1) IL126955A (pt)
MY (1) MY115619A (pt)
NO (1) NO312546B1 (pt)
NZ (1) NZ332633A (pt)
PL (1) PL329596A1 (pt)
PT (1) PT915087E (pt)
RU (1) RU2223951C2 (pt)
SI (1) SI0915087T1 (pt)
SK (1) SK283866B6 (pt)
TR (1) TR199802270A2 (pt)
TW (1) TW427970B (pt)
ZA (1) ZA9810202B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911914B1 (pt) * 1998-07-08 2010-10-19 n-arilamidas do ácido sulfonilaminocarboxìlico substituìdas por enxofre, processo para sua preparação, bem como preparações farmacêuticas que compreendem as mesmas.
DE19929076A1 (de) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
US6458794B2 (en) 1999-12-21 2002-10-01 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
JP4197649B2 (ja) * 2001-12-12 2008-12-17 エフ.ホフマン−ラ ロシュ アーゲー アデノシン受容体モジュレーターとしてのベンゾチオフェン
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
US7932284B2 (en) * 2006-01-24 2011-04-26 Eli Lilly And Company Indole sulfonamide modulators of progesterone receptors
JP2009026126A (ja) * 2007-07-20 2009-02-05 Nec Electronics Corp 半導体装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8602606A1 (es) * 1983-03-04 1985-12-01 Otsuka Pharma Co Ltd Derivados de indano y sus sales
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
CN1219533A (zh) 1999-06-16
AR016006A1 (es) 2001-05-30
TR199802270A2 (xx) 1999-05-21
HU9802590D0 (en) 1999-01-28
HRP980585A2 (en) 1999-06-30
RU2223951C2 (ru) 2004-02-20
HUP9802590A3 (en) 2001-08-28
SK283866B6 (sk) 2004-03-02
US6015822A (en) 2000-01-18
ZA9810202B (en) 1999-05-10
CZ363798A3 (cs) 1999-05-12
CA2253211C (en) 2009-04-14
BR9804995A (pt) 2001-05-22
NO985171L (no) 1999-05-11
IL126955A (en) 2002-11-10
CA2253211A1 (en) 1999-05-10
IL126955A0 (en) 1999-09-22
NO312546B1 (no) 2002-05-27
EP0915087A3 (de) 1999-07-21
EP0915087A2 (de) 1999-05-12
ES2196456T3 (es) 2003-12-16
TW427970B (en) 2001-04-01
SK154598A3 (en) 1999-06-11
DE19749453A1 (de) 1999-05-12
JPH11236368A (ja) 1999-08-31
JP4331809B2 (ja) 2009-09-16
SI0915087T1 (en) 2003-10-31
ID21282A (id) 1999-05-12
NO985171D0 (no) 1998-11-05
HRP980585B1 (en) 2003-02-28
DE59807718D1 (de) 2003-05-08
EP0915087B1 (de) 2003-04-02
DK0915087T3 (da) 2003-07-21
AU9139898A (en) 1999-05-27
HUP9802590A2 (hu) 2000-04-28
NZ332633A (en) 2000-05-26
MY115619A (en) 2003-07-31
ATE236120T1 (de) 2003-04-15
KR19990045147A (ko) 1999-06-25
AU742199B2 (en) 2001-12-20
PL329596A1 (en) 1999-05-24

Similar Documents

Publication Publication Date Title
IS1950B (is) Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum
IS5130A (is) Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum
FI973278A (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
FI943570A (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
DE69820108D1 (de) Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien
NO953657D0 (no) Nytt farmasöytisk produkt
NL300249I2 (en) Cephalosporins and homologues, preparations and pharmaceutical preparations.
NO965103L (no) Bicykliske aromatiske forbindelser, anvendelse derav, og farmasöytiske og kosmetiske preparater
BR9711098B1 (pt) compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
FR08C0025I2 (fr) Heterocycles bicycliques disubstitues, production et utilisation comme medicaments
NO922005D0 (no) Farmasoeytiske preparater
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69017333D1 (de) Kosmetisches Mittel.
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
FI873630A0 (fi) Stabilt farmaceutiskt preparat.
ITRM920237A1 (it) Perfezionato impiego di medicinali broncodilatatori b2.
BR9708004A (pt) PirimidoÚ5,4¾pirimidinas medicamentos contendo estes compostos seu emprego e processos para sua preparação
AR002982A1 (es) Benzonitrilos y benzofluoruros, un procedimiento para prepararlos, su empleo para preparar médicamentos, un médicamento hecho a base de estos compuestos, las preparaciónes farmacéuticas que los contienen y un procedimiento para obtener estas preparaciónes farmacéuticas.
NO965102D0 (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
PT915087E (pt) Compostos anelados de cinco aneis, susbtituidos por sulfonamida, sua utilizacao como medicamentos, bem como preparacoes farmaceuticas contendo os mesmos
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
FI961938A0 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.